MPW Investors Have Opportunity to Lead Medical Properties Trust, Inc. Securities Fraud Lawsuit


Werte in diesem Artikel
Aktien

3.10 EUR -0.06 EUR -1.83 %

LOS ANGELES, Nov. 21, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medical Properties Trust, Inc. ("MPW" or the "Company") (NYSE: MPW).

Class Period: May 23, 2023 – August 17, 2023
Lead Plaintiff Deadline:November 28, 2023

If you wish to serve as lead plaintiff of the MPW lawsuit, you can submit your contact information at www.glancylaw.com/cases/Medical-Properties-Trust-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: 1) the Recap Transaction was subject to regulatory approval and had in fact been placed on hold by the DMHC; (2) accordingly, MPW had misrepresented the regulatory process for the Recap Transaction's approval; (3) as a result of the foregoing, MPW overstated the approval prospects and benefits of the Recap Transaction; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Cision View original content:https://www.prnewswire.com/news-releases/mpw-investors-have-opportunity-to-lead-medical-properties-trust-inc-securities-fraud-lawsuit-301995208.html

SOURCE Glancy Prongay & Murray LLP

Aktuelle Medical Properties Trust Aktie News

Werbung

Medical Properties Trust Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Medical Properties Trust nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
03.09.19 Medical Properties Trust Overweight Barclays Capital
10.01.18 Medical Properties Trust Hold Deutsche Bank AG
05.01.18 Medical Properties Trust Neutral Robert W. Baird & Co. Incorporated
10.03.17 Medical Properties Trust Outperform Robert W. Baird & Co. Incorporated
22.11.16 Medical Properties Trust Equal Weight Barclays Capital

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.